Karhula Maarit E, Salminen Anna-Liisa, Hämäläinen Päivi I, Ruutiainen Juhani, Era Pertti, Tolvanen Asko
a Department of Social and Health Care , Mikkeli University of Applied Sciences , Mikkeli , Finland.
b Department of Health Sciences , University of Jyväskylä , Jyväskylä , Finland.
Scand J Occup Ther. 2017 Nov;24(6):410-420. doi: 10.1080/11038128.2016.1272630. Epub 2017 Jan 3.
The objective of this study was to evaluate the psychometric properties of the impact on participation and autonomy (IPA) questionnaire. The Finnish version of IPA (IPAFin) was translated into Finnish using the protocol for linguistic validation for patient-reported outcomes instruments.
A total of 194 persons with multiple sclerosis (MS) (mean age 50 years SD 9, 72% female) with moderate to severe disability participated in this study. A confirmatory factor analysis (CFA) was used to confirm the four factor structure of the IPAFin. The work and educational opportunities domain was excluded from analysis, because it was only applicable to 51 persons. Internal consistency was investigated by calculating Cronbach's alpha.
CFA confirmed the construct validity of the IPA (standardized root mean square residual (SRMR) = 0.06, comparative fit index (CFI) = 0.93, Tucker-Lewis index =0.93, root mean square error of approximation (RMSEA) = 0.06), indicating a good fit to the model. There was no difference in the models for females and males. Cronbach's alpha for the domains ranged between 0.80 and 0.91, indicating good homogeneity.
The construct validity and reliability of the IPAFin is acceptable. IPAFin is a suitable measure of participation in persons with MS.
本研究旨在评估参与和自主功能影响问卷(IPA)的心理测量特性。采用患者报告结局工具语言验证方案,将芬兰语版的IPA(IPAFin)翻译成芬兰语。
共有194名中度至重度残疾的多发性硬化症(MS)患者(平均年龄50岁,标准差9,72%为女性)参与了本研究。采用验证性因子分析(CFA)来确认IPAFin的四因子结构。工作和教育机会领域被排除在分析之外,因为它仅适用于51人。通过计算Cronbach's α系数来研究内部一致性。
CFA证实了IPA的结构效度(标准化均方根残差(SRMR)=0.06,比较拟合指数(CFI)=0.93,塔克-刘易斯指数=0.93,近似均方根误差(RMSEA)=0.06),表明模型拟合良好。男性和女性的模型没有差异。各领域的Cronbach's α系数在0.80至0.91之间,表明同质性良好。
IPAFin的结构效度和信度是可接受的。IPAFin是衡量MS患者参与度的合适指标。